2017 Fiscal Year Final Research Report
An Approach to Develop High-Performance Photosensitizers Based on Silyl-Substituted Porphyrin Molecules for Photodynamic Therapy
Project/Area Number |
15K07874
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Chemical pharmacy
|
Research Institution | Meiji Pharmaceutical University |
Principal Investigator |
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Keywords | 光線力学治療 / ポルフィリン光増感剤 / ケイ素官能基 / 酸化電位 / 吸収波長 / βーシリル化 / meso-シリル化 / シリル亜鉛反応剤 |
Outline of Final Research Achievements |
Photodynamic therapy (PDT) has been extensively considered as a promising and minimally invasive strategy for cancer therapy. The main two concerns associated with certain clinically-used PDT sensitizers are low tissue-penetrating depth of light and potential phototoxicity, which are expected to be solved by developing new PDT sensitizers that have a higher absorption coefficient in longer wavelength region, show lower cytotoxicity, and can quickly be excreted from human body by drug detoxification in a shorter time. Described herein is the synthesis, characterization, and photo- and electrochemical properties of meso- and β-sily-substituted porphyrins. Their unique optical- and electrochemical properties imply that the silyl-substituted porphyrin derivatives could be a promising anticancer agent for photodynamic therapy.
|
Free Research Field |
物理有機化学
|